Skip to content
Summit Arena Space covers the latest in space technology, e…

Zimbabwe Declines ‘Unbalanced’ US Healthcare Assistance Agreement Because of Information Fears

Medical aid illustration
The proposed American funding was intended for programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has rejected a substantial US health deal worth 367 million US dollars (272 million pounds) over five years because of the United States' demand for sensitive information.

This move became public after a government memo from December was leaked, indicating that President Emmerson Mnangagwa believed the agreement was "lopsided".

An official spokesman later clarified that the United States was seeking genetic material for scientific study and profit but was not willing to guarantee the benefits from any future vaccines.

"We will now turn to the difficult and regrettable process of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the US had provided more than $1.9bn for health programmes to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has called for continued negotiations to find a agreement acceptable to both sides so the country's critical HIV treatment initiative can continue.

Wider Background

This rejection comes after a comparable case in Kenya, where a high court suspended a related health funding agreement after concerns were raised about the safety of citizens' medical information.

After returning to the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.

The agency had managed aid for the American government, but Trump argued its expenditure was "wasteful" and his administration was seeking direct bilateral deals to boost openness and accountability.

Based on statements, 16 nations in Africa have so far signed these new agreements, representing more than $18.3bn of fresh investment.

Specifics of the Rejected Deal

This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".

"We are confident this collaboration could have provided extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving HIV treatment via American-funded initiatives," Tremont commented.

However, government spokesperson Nick Mangwana said the arrangement was "unfair".

"Zimbabwe was being asked to provide its biological resources and data over an extended period, without any equivalent guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that shared data," he stated.

"In essence, our nation would provide the raw materials for medical research with no certainty that the final treatments would be available to our population if a new pandemic emerge."

Sovereignty and Global Health

He also said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were upending frameworks previously set up through the global organization.

The spokesperson cited its Pandemic Benefit-Sharing scheme designed to manage potential global health emergencies.

"This mechanism is designed to guarantee that when a nation provides its information, the resulting advantages – including medicines and cures – are shared equitably, not commercialised exclusively by those with the capability to develop them."

The government's concerns over the US deal "are not meant as anti-American sentiment," Mangwana stressed.

"We encourage further discussions with our American counterparts on how subsequent collaboration could be designed in a way that honours the independence and dignity of both nations."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but recommended that talks need to persist since a large portion of the nation's HIV programmes were funded by foreign aid.

"If specific concerns exist, including those involving data governance or implementation frameworks, these can often be addressed via detailed discussion and negotiated safeguards," the group said.

The situation underscores the ongoing debate between receiving crucial international aid and protecting local interests in an increasingly data-driven world.

By

Sharon Haynes

Aerospace engineer and science communicator passionate about making space accessible to everyone.

Summit Arena Space

Type to search articles.